ALT earnings: a positive outcome, +7.8%

On May 9, 2024, Altimmune, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.8% in the window around the event. It had already run -12.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.